Xiaojuan Ou

2.0k total citations
93 papers, 939 citations indexed

About

Xiaojuan Ou is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Xiaojuan Ou has authored 93 papers receiving a total of 939 indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Epidemiology, 53 papers in Hepatology and 14 papers in Surgery. Recurrent topics in Xiaojuan Ou's work include Liver Disease Diagnosis and Treatment (53 papers), Hepatitis B Virus Studies (36 papers) and Hepatitis C virus research (27 papers). Xiaojuan Ou is often cited by papers focused on Liver Disease Diagnosis and Treatment (53 papers), Hepatitis B Virus Studies (36 papers) and Hepatitis C virus research (27 papers). Xiaojuan Ou collaborates with scholars based in China, United States and Singapore. Xiaojuan Ou's co-authors include Jidong Jia, Hong You, Yuanyuan Kong, Xinyan Zhao, Shanshan Wu, Yameng Sun, Hong Ma, Weijia Duan, Xiaoning Wu and Qianyi Wang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Hepatology.

In The Last Decade

Xiaojuan Ou

89 papers receiving 927 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaojuan Ou China 17 642 558 183 87 73 93 939
Nirupama Trehanpati India 15 618 1.0× 635 1.1× 198 1.1× 214 2.5× 93 1.3× 27 1.1k
R Vecchione Italy 14 518 0.8× 364 0.7× 197 1.1× 170 2.0× 103 1.4× 35 928
Marco Biolato Italy 18 455 0.7× 420 0.8× 150 0.8× 135 1.6× 95 1.3× 50 965
Jaswinder Singh Maras India 15 366 0.6× 248 0.4× 104 0.6× 239 2.7× 44 0.6× 61 749
Richard Skoien Australia 13 817 1.3× 419 0.8× 178 1.0× 181 2.1× 37 0.5× 33 1.1k
Takanori Hosokawa Japan 21 841 1.3× 921 1.7× 98 0.5× 158 1.8× 115 1.6× 33 1.2k
C. Bertelli Italy 13 856 1.3× 324 0.6× 173 0.9× 114 1.3× 29 0.4× 22 1.1k
Michel Mendler United States 17 548 0.9× 492 0.9× 195 1.1× 87 1.0× 63 0.9× 35 1.1k
Yasuaki Takeyama Japan 13 268 0.4× 219 0.4× 201 1.1× 80 0.9× 203 2.8× 67 617
Arlène K. van Vliet Netherlands 17 342 0.5× 497 0.9× 645 3.5× 166 1.9× 100 1.4× 27 1.1k

Countries citing papers authored by Xiaojuan Ou

Since Specialization
Citations

This map shows the geographic impact of Xiaojuan Ou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojuan Ou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojuan Ou more than expected).

Fields of papers citing papers by Xiaojuan Ou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojuan Ou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojuan Ou. The network helps show where Xiaojuan Ou may publish in the future.

Co-authorship network of co-authors of Xiaojuan Ou

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojuan Ou. A scholar is included among the top collaborators of Xiaojuan Ou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojuan Ou. Xiaojuan Ou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Zhiying, Zhongjie Hu, Chunqing Zhang, et al.. (2025). Unstable Recompensation: An Intermediate Subtype in Patients With HBV ‐Related Decompensated Cirrhosis. Alimentary Pharmacology & Therapeutics. 63(5). 715–727. 2 indexed citations
2.
Xu, Hui, Dawei Yang, Xinyan Zhao, et al.. (2024). Intravoxel incoherent motion assessment of liver fibrosis staging in MASLD. Abdominal Radiology. 49(5). 1411–1418. 3 indexed citations
3.
Yang, Dawei, Hui Xu, Xinyan Zhao, et al.. (2024). The staging of nonalcoholic fatty liver disease fibrosis: A comparative study of MR elastography and the quantitative DCE-MRI exchange model. Heliyon. 10(2). e24558–e24558. 1 indexed citations
4.
Li, Minghui, Xiaojuan Ou, Sujun Zheng, et al.. (2023). Lower end of treatment HBsAg and HBcrAg were associated with HBsAg loss after nucleos(t)ide analog cessation. BMC Gastroenterology. 23(1). 224–224. 4 indexed citations
5.
Zhao, Jingjie, Qianyi Wang, Lina Wu, et al.. (2023). Electro-acupuncture reduced steatosis on MRI-PDFF in patients with non-alcoholic steatohepatitis: a randomized controlled pilot clinical trial. Chinese Medicine. 18(1). 19–19. 5 indexed citations
6.
Luo, Jia, Dawei Yang, Dai Zhang, et al.. (2023). A prospective study on the differential association of sarcopenia and frailty with health outcomes in cirrhotic patients. Digestive and Liver Disease. 55(11). 1533–1542. 2 indexed citations
7.
Wang, Qianyi, Xinyan Zhao, Yameng Sun, et al.. (2022). Histological assessment based on liver biopsy: the value and challenges in NASH drug development. Acta Pharmacologica Sinica. 43(5). 1200–1209. 23 indexed citations
8.
Wu, Liyan, Wei Zhang, Yanmeng Li, et al.. (2021). Correlation of genotype and phenotype in 32 patients with hereditary hemochromatosis in China. Orphanet Journal of Rare Diseases. 16(1). 398–398. 7 indexed citations
9.
Wu, Xiaoning, Jialing Zhou, Yameng Sun, et al.. (2021). Health-related quality of life improves after entecavir treatment in patients with compensated HBV cirrhosis. Hepatology International. 15(6). 1318–1327. 11 indexed citations
10.
Wu, Lina, Yanmeng Li, Yi Song, et al.. (2020). A recurrent ABCC2 p.G693R mutation resulting in loss of function of MRP2 and hyperbilirubinemia in Dubin-Johnson syndrome in China. Orphanet Journal of Rare Diseases. 15(1). 74–74. 13 indexed citations
11.
Sun, Yameng, Xiaoning Wu, Jialing Zhou, et al.. (2020). Persistent Low Level of Hepatitis B Virus Promotes Fibrosis Progression During Therapy. Clinical Gastroenterology and Hepatology. 18(11). 2582–2591.e6. 72 indexed citations
12.
Tian, Qiuju, Xinyan Zhao, Yan Wang, et al.. (2019). Histologic pattern is better correlated with clinical outcomes than biochemical classification in patients with drug-induced liver injury. Modern Pathology. 32(12). 1795–1805. 8 indexed citations
13.
Wu, Xiaoning, Jialing Zhou, Wen Xie, et al.. (2019). <p>Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study</p>. Infection and Drug Resistance. Volume 12. 745–757. 8 indexed citations
14.
Zhang, Wei, Xinyan Zhao, Jian Huang, Xiaojuan Ou, & Jidong Jia. (2019). Alagille syndrome: an uncommon cause of intrahepatic cholestasis in adults. Revista Española de Enfermedades Digestivas. 111(4). 323–326. 6 indexed citations
15.
Sun, Yameng, Jialing Zhou, Xiaoning Wu, et al.. (2018). Quantitative assessment of liver fibrosis (qFibrosis) reveals precise outcomes in Ishak “stable” patients on anti-HBV therapy. Scientific Reports. 8(1). 2989–2989. 32 indexed citations
16.
Zeng, Na, Zhiying He, Hong Ma, et al.. (2017). Systematic review on the reporting quality of randomized controlled trials in patients with hepatitis B or C in China. International Journal of Infectious Diseases. 67. 58–64. 6 indexed citations
17.
Zhang, Wei, Xiaomin Wang, Yu Wang, et al.. (2017). Effective viral suppression is necessary to reduce hepatocellular carcinoma development in cirrhotic patients with chronic hepatitis B. Medicine. 96(44). e8454–e8454. 14 indexed citations
18.
He, Xiaomin, Hong Yu, Xiaomei Wang, et al.. (2016). Identification and clinical significance of an elevated level of serum aminoacylase-1 autoantibody in patients with hepatitis B virus-related liver cirrhosis. Molecular Medicine Reports. 14(5). 4255–4262. 12 indexed citations
19.
Hou, Jinlin, Huiguo Ding, Guofeng Chen, et al.. (2015). Validation of Ten Noninvasive Diagnostic Models for Prediction of Liver Fibrosis in Patients with Chronic Hepatitis B. PLoS ONE. 10(12). e0144425–e0144425. 22 indexed citations
20.
Tang, Wen, Yu Wang, Xinyan Zhao, et al.. (2015). Procoagulant imbalance aggravated with falling liver function reserve, but not associated with the presence of portal vein thrombosis in cirrhosis. European Journal of Gastroenterology & Hepatology. 27(6). 672–678. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nirupama Trehanpati Breakdown of academic impact, for papers by R Vecchione Breakdown of academic impact, for papers by Marco Biolato Breakdown of academic impact, for papers by Jaswinder Singh Maras Breakdown of academic impact, for papers by Richard Skoien Breakdown of academic impact, for papers by Takanori Hosokawa Breakdown of academic impact, for papers by C. Bertelli Breakdown of academic impact, for papers by Michel Mendler Breakdown of academic impact, for papers by Yasuaki Takeyama Breakdown of academic impact, for papers by Arlène K. van Vliet
Rankless by CCL
2026